Status:
UNKNOWN
Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Ludwig-Maximilians - University of Munich
Universitätsklinikum Hamburg-Eppendorf
Conditions:
COVID-19 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronavirus (COVID-19) vaccines have saved millions of lives since release and remain a key tool in the fight against the pandemic. However, most countries have not reached the vaccine uptake rates n...
Detailed Description
The iWILL study is a cross sectional study that aims to evaluate the effectiveness of interactive risk ratio simulation (intervention) relative to a text-based format (control) in COVID-19 vaccine-hes...
Eligibility Criteria
Inclusion
- Hesitancy towards COVID-19 vaccination
- Not yet vaccinated against COVID-19
- Age ≥ 18 years.
Exclusion
- No hesitancy towards COVID-19 vaccination
- Already vaccinated
- Age \< 18 years.
Key Trial Info
Start Date :
February 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
1188 Patients enrolled
Trial Details
Trial ID
NCT05193903
Start Date
February 3 2022
End Date
February 28 2023
Last Update
December 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany